Current Drug Targets
Title:Editorial (Thematic Issue: From Multiple Hits to Multiple Therapeutic Targets of Non-alcoholic Fatty Liver Disease)
Volume: 16 Issue: 12
Author(s): Lixin Zhu, Robert D. Baker and Susan S. Baker
Affiliation:
Export Options
About this article
Cite this article as:
Zhu Lixin, Baker D. Robert and Baker S. Susan, Editorial (Thematic Issue: From Multiple Hits to Multiple Therapeutic Targets of Non-alcoholic Fatty Liver Disease), Current Drug Targets 2015; 16 (12) . https://dx.doi.org/10.2174/1389450116999150928154553
DOI https://dx.doi.org/10.2174/1389450116999150928154553 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Efficacy and Activity Prediction by Molecular Topology of New Drugs Against the Tetranychus urticae Plague
Combinatorial Chemistry & High Throughput Screening CB Receptor Ligands from Plants
Current Topics in Medicinal Chemistry Synthetic Glucocorticoids: Antenatal Administration and Long-term Implications
Current Pharmaceutical Design Microvascular Alterations in Hypertension and Vascular Aging
Current Hypertension Reviews Inflammatory Modulation of Hepatocyte Apoptosis by Nitric Oxide: In Vivo, In Vitro, and In Silico Studies
Current Molecular Medicine Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Reviews on Recent Clinical Trials Molecular and Pharmacological Characterization of Hamster HCA1 and HCA2
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Biosafety of Adenoviral Vectors
Current Gene Therapy Immune System Alterations by Aldosterone During Hypertension: From Clinical Observations to Genomic and Non-Genomic Mechanisms Leading to Vascular Damage
Current Molecular Medicine Functional Biomarkers: an Approach to Bridge Pharmacokinetics and Pharmacodynamics in Pediatric Clinical Trials
Current Pharmaceutical Design Haptoglobin Genotype Affects Inflammation after Aneurysmal Subarachnoid Hemorrhage
Current Neurovascular Research Novel Biomarkers for Lupus Nephritis in the “OMICS” Era
Current Medicinal Chemistry Biochemical Screening for in utero Drug Exposure
Drug Metabolism Letters The Impact of Docosahexaenoic Acid on Alzheimer’s Disease: Is There a Role of the Blood-Brain Barrier?
Current Clinical Pharmacology The Janus Face of Adenosine: Antiarrhythmic and Proarrhythmic Actions
Current Pharmaceutical Design Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response
Current Molecular Medicine Management of Hypertension in Relation to Acute Coronary Syndromes and Revascularisation
Current Pharmaceutical Design REM Sleep Loss and Recovery Regulates Blood-Brain Barrier Function
Current Neurovascular Research Inhibitors of HIV-1 Gene Expression and Transcription
Current Topics in Medicinal Chemistry Valproic Acid in the Complex Therapy of Malignant Tumors
Current Drug Targets